Terez, Marven D.
HRN: 24-89-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
CEFUROXIME 750MG (VIAL)
04/26/2024
05/03/2024
IV
750mg
Q8hrs
T/C Nasal Bone Fracture; T/C TBI
Waiting Final Action
Indication: Prophylaxis Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes